Syra Health Corp (SYRA) can make a big difference with a little luck

With 1.59 million shares changed hands, the volume of the stock remained heavier than its average volume of 0.49 million shares. During the session, the Medical Care Facilities company that operates in wider Healthcare sector, reached to the highest price of $2.0 whereas the lowest price it dropped to was $1.62. The 52-week range on SYRA shows that it touched its highest point at $8.37 and its lowest point at $0.81 during that stretch.

Price Performance and Earnings:

Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of SYRA was down-trending over the past week, with a drop of -20.56%, but this was up by 38.21% over a month. Three-month performance dropped to -38.63% while six-month performance rose 28.79%.

Float and Shares Shorts:

On 2024-04-30, short shares totaled 0.26 million, which was 392.0 higher than short shares on 1711584000. In addition to Mr. Sandeep Allam as the firm’s Co-Founder, Executive Chairman & President, Dr. Deepika Vuppalanchi Ph.D. serves as its Co-Founder, CEO & Director.

Institutional Ownership:

Through their ownership of 0.02542 of SYRA’s outstanding shares, institutional investors have minority control over the company.

An Overview of Recent Financials:

Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on 2024-03-31, SYRA reported revenue of $1752340.0 and operating income of -$1406208.0. The EBITDA in the recently reported quarter was -$1392682.0 and diluted EPS was -$0.22.

Analysts Ratings:

Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for SYRA since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential.